Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABT Abbott Laboratories	$131.24 -0.1%	$129.71	$99.71 ▼ $141.23	$227.97B	0.7	5.46 million shs	1.60 million shs
BAX Baxter International	$33.69 0.0%	$33.14	$28.34 ▼ $43.99	$17.28B	0.6	4.24 million shs	270,051 shs
BSX Boston Scientific	$98.66 -2.1%	$102.15	$66.80 ▼ $107.17	$146.00B	0.77	5.80 million shs	1.94 million shs
ISRG Intuitive Surgical	$493.27 -2.9%	$558.29	$364.17 ▼ $616.00	$175.75B	1.43	1.46 million shs	235,296 shs
KO Coca-Cola	$71.21 +0.7%	$67.62	$57.93 ▼ $73.53	$306.57B	0.57	14.02 million shs	1.97 million shs
MDT Medtronic	$87.37 -1.0%	$91.00	$75.96 ▼ $96.25	$112.30B	0.8	6.10 million shs	698,039 shs
MMM 3M	$146.17 -1.5%	$149.52	$87.45 ▼ $156.35	$79.41B	0.97	3.98 million shs	378,548 shs
SWK Stanley Black & Decker	$76.68 -1.3%	$85.19	$76.61 ▼ $110.88	$11.88B	1.25	1.53 million shs	189,083 shs
SYK Stryker	$365.67 -0.5%	$384.47	$314.93 ▼ $406.19	$139.68B	0.95	1.23 million shs	109,884 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABT Abbott Laboratories	+4.12%	+3.91%	-3.21%	+14.50%	+16.04%
BAX Baxter International	+1.12%	+0.86%	-6.23%	+15.61%	-20.92%
BSX Boston Scientific	-1.53%	-0.79%	-0.18%	+11.12%	+46.81%
ISRG Intuitive Surgical	-0.22%	+3.27%	-11.48%	-5.04%	+26.94%
KO Coca-Cola	+1.12%	+1.69%	-1.03%	+13.37%	+16.01%
MDT Medtronic	+0.93%	-2.37%	-1.73%	+10.22%	+2.39%
MMM 3M	-2.73%	-1.77%	+1.32%	+14.06%	+41.93%
SWK Stanley Black & Decker	-0.89%	-3.47%	-11.37%	-3.52%	-19.91%
SYK Stryker	+0.15%	-1.56%	-5.81%	+0.21%	+2.46%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABT Abbott Laboratories	4.8566 of 5 stars	2.4	4.0	2.5	4.5	4.1	2.5	2.5
BAX Baxter International	4.615 of 5 stars	2.2	5.0	1.7	4.0	2.8	1.7	2.5
BSX Boston Scientific	4.2537 of 5 stars	2.5	4.0	0.0	4.2	3.1	2.5	1.3
ISRG Intuitive Surgical	4.5734 of 5 stars	3.3	3.0	0.0	4.0	3.0	2.5	1.9
KO Coca-Cola	4.1643 of 5 stars	2.5	3.0	3.3	0.8	3.5	2.5	1.3
MDT Medtronic	4.4539 of 5 stars	2.2	4.0	3.3	4.0	3.5	2.5	0.6
MMM 3M	4.2501 of 5 stars	2.3	3.0	2.5	2.8	3.5	2.5	1.3
SWK Stanley Black & Decker	4.6993 of 5 stars	4.2	1.0	4.2	1.9	2.8	1.7	1.9
SYK Stryker	4.7808 of 5 stars	3.4	3.0	3.3	4.2	3.0	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABT Abbott Laboratories	2.84	Moderate Buy	$137.94	5.10% Upside
BAX Baxter International	2.40	Hold	$38.56	14.45% Upside
BSX Boston Scientific	3.00	Buy	$108.91	10.39% Upside
ISRG Intuitive Surgical	2.67	Moderate Buy	$611.86	24.04% Upside
KO Coca-Cola	3.00	Buy	$74.24	4.25% Upside
MDT Medtronic	2.44	Hold	$96.07	9.96% Upside
MMM 3M	2.63	Moderate Buy	$149.13	2.03% Upside
SWK Stanley Black & Decker	2.30	Hold	$102.20	33.28% Upside
SYK Stryker	2.80	Moderate Buy	$421.90	15.38% Upside

Current Analyst Ratings Breakdown

Latest SYK, BAX, MDT, ISRG, SWK, KO, ABT, BSX, and MMM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/26/2025	SWK Stanley Black & Decker	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$94.00 ➝ $86.00
3/22/2025	MMM 3M	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold (C+) ➝ Hold (C+)
3/21/2025	SYK Stryker	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$442.00 ➝ $442.00
3/18/2025	ISRG Intuitive Surgical	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$707.00 ➝ $600.00
3/17/2025	ISRG Intuitive Surgical	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
3/17/2025	ISRG Intuitive Surgical	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$666.00 ➝ $605.00
3/10/2025	ABT Abbott Laboratories	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$133.00 ➝ $150.00
3/10/2025	BAX Baxter International	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$39.00 ➝ $41.00
3/7/2025	MMM 3M	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold (C) ➝ Hold (C+)
3/6/2025	MMM 3M	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$175.00 ➝ $179.00
3/4/2025	SYK Stryker	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$422.00

(Data available from 3/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABT Abbott Laboratories	$41.95B	5.43	$5.65 per share	23.22	$22.36 per share	5.87
BAX Baxter International	$10.64B	1.62	$5.22 per share	6.45	$16.69 per share	2.02
BSX Boston Scientific	$16.75B	8.71	$3.42 per share	28.86	$14.91 per share	6.62
ISRG Intuitive Surgical	$8.35B	21.04	$6.50 per share	75.93	$46.41 per share	10.63
KO Coca-Cola	$47.06B	6.51	$3.19 per share	22.29	$6.12 per share	11.64
MDT Medtronic	$33.20B	3.38	$7.16 per share	12.21	$38.69 per share	2.26
MMM 3M	$24.58B	3.23	$9.81 per share	14.90	$7.17 per share	20.39
SWK Stanley Black & Decker	$15.37B	0.77	$6.91 per share	11.10	$56.47 per share	1.36
SYK Stryker	$22.60B	6.18	$14.27 per share	25.62	$54.08 per share	6.76

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABT Abbott Laboratories	$13.40B	$7.65	17.18	22.90	2.52	31.95%	20.74%	11.19%	4/16/2025 (Estimated)
BAX Baxter International	-$649M	-$1.28	N/A	12.34	0.93	-5.05%	16.67%	4.93%	5/1/2025 (Estimated)
BSX Boston Scientific	$1.85B	$1.25	78.97	30.54	2.79	11.07%	17.80%	9.85%	4/23/2025 (Estimated)
ISRG Intuitive Surgical	$2.32B	$6.41	76.98	64.65	5.85	27.81%	14.55%	12.88%	4/22/2025 (Estimated)
KO Coca-Cola	$10.63B	$2.47	28.84	22.32	3.79	22.59%	45.37%	12.24%	4/29/2025 (Estimated)
MDT Medtronic	$3.68B	$3.29	26.61	14.99	2.22	12.83%	14.07%	7.70%	5/21/2025 (Estimated)
MMM 3M	$4.17B	$7.55	19.37	17.55	3.30	15.71%	100.77%	9.84%	4/29/2025 (Estimated)
SWK Stanley Black & Decker	$294.30M	$1.94	39.63	12.19	1.33	1.92%	7.50%	2.91%	5/1/2025 (Estimated)
SYK Stryker	$2.99B	$7.76	47.17	24.66	2.93	13.25%	23.58%	11.37%	4/29/2025 (Estimated)

Latest SYK, BAX, MDT, ISRG, SWK, KO, ABT, BSX, and MMM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/23/2025	N/A	BSX Boston Scientific	$0.67	N/A	N/A	N/A	$4.57 billion	N/A
4/22/2025	N/A	ISRG Intuitive Surgical	$1.71	N/A	N/A	N/A	$2.19 billion	N/A
4/16/2025	N/A	ABT Abbott Laboratories	$1.07	N/A	N/A	N/A	$10.38 billion	N/A
2/20/2025	Q4 2024	BAX Baxter International	$0.52	$0.58	+$0.06	-$1.00	$2.67 billion	$2.75 billion
2/18/2025	Q3 2025	MDT Medtronic	$1.36	$1.39	+$0.03	$1.01	$8.33 billion	$8.29 billion
2/11/2025	Q4 2024	KO Coca-Cola	$0.51	$0.55	+$0.04	$0.51	$10.70 billion	N/A
2/5/2025	Q4 2024	BSX Boston Scientific	$0.65	$0.70	+$0.05	$0.38	$4.42 billion	N/A
2/5/2025	Q4 2024	SWK Stanley Black & Decker	$1.28	$1.49	+$0.21	$1.28	$3.58 billion	N/A
1/28/2025	Q4 2024	SYK Stryker	$3.87	$4.01	+$0.14	$1.41	$6.36 billion	N/A
1/22/2025	Q4 2024	ABT Abbott Laboratories	$1.34	$1.34	N/A	$5.27	$11.03 billion	$10.97 billion
1/21/2025	Q4 2024	MMM 3M	$1.66	$1.68	+$0.02	$1.33	$5.77 billion	$6.01 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABT Abbott Laboratories	$2.36	1.80%	N/A	30.85%	N/A
BAX Baxter International	$0.68	2.02%	-1.40%	N/A	N/A
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
KO Coca-Cola	$2.04	2.86%	+4.91%	82.59%	64 Years
MDT Medtronic	$2.80	3.20%	+4.14%	85.11%	48 Years
MMM 3M	$2.92	2.00%	-15.20%	38.68%	N/A
SWK Stanley Black & Decker	$3.28	4.28%	+3.04%	169.07%	58 Years
SYK Stryker	$3.36	0.92%	+7.82%	43.30%	32 Years

Latest SYK, BAX, MDT, ISRG, SWK, KO, ABT, BSX, and MMM Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/21/2025	ABT Abbott Laboratories	quarterly	$0.59	1.75%	4/15/2025	4/15/2025	5/15/2025
2/5/2025	SYK Stryker	quarterly	$0.84	0.86%	3/31/2025	3/31/2025	4/30/2025
3/6/2025	MDT Medtronic	quarterly	$0.70	3%	3/28/2025	3/28/2025	4/11/2025
2/11/2025	BAX Baxter International	quarterly	$0.17	2.22%	2/28/2025	2/28/2025	4/1/2025
2/20/2025	KO Coca-Cola	quarterly	$0.51	2.9%	3/14/2025	3/14/2025	4/1/2025
2/18/2025	SWK Stanley Black & Decker	quarterly	$0.82	3.77%	3/4/2025	3/4/2025	3/18/2025
2/4/2025	MMM 3M	quarterly	$0.73	1.92%	2/14/2025	2/14/2025	3/12/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABT Abbott Laboratories	0.32	1.60	1.14
BAX Baxter International	1.31	1.43	1.09
BSX Boston Scientific	0.41	1.08	1.02
ISRG Intuitive Surgical	N/A	4.07	3.22
KO Coca-Cola	1.61	1.03	0.84
MDT Medtronic	0.48	1.90	1.39
MMM 3M	2.86	1.41	1.08
SWK Stanley Black & Decker	0.64	1.30	0.37
SYK Stryker	0.59	1.95	1.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABT Abbott Laboratories	75.18%
BAX Baxter International	90.19%
BSX Boston Scientific	89.07%
ISRG Intuitive Surgical	83.64%
KO Coca-Cola	70.26%
MDT Medtronic	82.06%
MMM 3M	65.25%
SWK Stanley Black & Decker	87.77%
SYK Stryker	77.09%

Insider Ownership

Company	Insider Ownership
ABT Abbott Laboratories	0.46%
BAX Baxter International	0.21%
BSX Boston Scientific	0.50%
ISRG Intuitive Surgical	0.90%
KO Coca-Cola	0.97%
MDT Medtronic	0.20%
MMM 3M	0.34%
SWK Stanley Black & Decker	0.70%
SYK Stryker	5.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABT Abbott Laboratories	115,000	1.73 billion	1.73 billion	Optionable
BAX Baxter International	60,000	511.63 million	509.47 million	Optionable
BSX Boston Scientific	45,000	1.48 billion	1.47 billion	Optionable
ISRG Intuitive Surgical	12,100	356.18 million	352.97 million	Optionable
KO Coca-Cola	82,500	4.30 billion	4.27 billion	Optionable
MDT Medtronic	95,000	1.28 billion	1.28 billion	Optionable
MMM 3M	92,000	542.90 million	541.05 million	Optionable
SWK Stanley Black & Decker	54,200	154.54 million	153.64 million	Optionable
SYK Stryker	53,000	381.58 million	359.07 million	Optionable

SYK, BAX, MDT, ISRG, SWK, KO, ABT, BSX, and MMM Headlines

Recent News About These Companies

Norges Bank Takes Position in Stryker Co. (NYSE:SYK)

March 28 at 7:32 AM | marketbeat.com

Blair William & Co. IL Boosts Stake in Stryker Co. (NYSE:SYK)

March 28 at 7:19 AM | marketbeat.com

IQ EQ FUND MANAGEMENT IRELAND Ltd Sells 3,600 Shares of Stryker Co. (NYSE:SYK)

March 28 at 7:18 AM | marketbeat.com

Rockbridge Investment Management LCC Buys Shares of 1,069 Stryker Co. (NYSE:SYK)

March 28 at 7:18 AM | marketbeat.com

Howe & Rusling Inc. Sells 3,950 Shares of Stryker Co. (NYSE:SYK)

March 28 at 6:49 AM | marketbeat.com

NEOS Investment Management LLC Buys 4,619 Shares of Stryker Co. (NYSE:SYK)

March 28 at 6:40 AM | marketbeat.com

Sava Infond d.o.o. Invests $1.49 Million in Stryker Co. (NYSE:SYK)

March 28 at 6:21 AM | marketbeat.com

Elo Mutual Pension Insurance Co Sells 1,287 Shares of Stryker Co. (NYSE:SYK)

March 28 at 6:14 AM | marketbeat.com

WINTON GROUP Ltd Makes New Investment in Stryker Co. (NYSE:SYK)

March 28 at 6:13 AM | marketbeat.com

Stryker Co. (NYSE:SYK) Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd.

March 28 at 6:05 AM | marketbeat.com

Korea Investment CORP Sells 35,230 Shares of Stryker Co. (NYSE:SYK)

March 28 at 5:54 AM | marketbeat.com

Stryker Co. (NYSE:SYK) Shares Sold by Financial Counselors Inc.

March 28 at 5:26 AM | marketbeat.com

Stryker Co. (NYSE:SYK) Stake Raised by Modern Wealth Management LLC

March 28 at 4:58 AM | marketbeat.com

Stryker Athletics trying to improve this spring

March 27 at 9:56 AM | bryantimes.com

US Army Stryker armored vehicles roll into El Paso, West Texas to boost border security

March 27 at 9:56 AM | usatoday.com

3SYK : Stryker Options Trading: A Deep Dive into Market Sentiment

March 27 at 9:56 AM | benzinga.com

Mitsubishi UFJ Trust & Banking Corp Grows Stock Holdings in Stryker Co. (NYSE:SYK)

March 27 at 5:49 AM | marketbeat.com

TIAA Trust National Association Decreases Stock Holdings in Stryker Co. (NYSE:SYK)

March 27 at 5:22 AM | marketbeat.com

Troops in Stryker armored vehicles to patrol southern border

March 26 at 11:33 AM | taskandpurpose.com

Stryker announces intention to nominate Manny Maceda to board of directors

March 26 at 10:15 AM | globenewswire.com

PKS Advisory Services LLC Invests $904,000 in Stryker Co. (NYSE:SYK)

March 26 at 6:47 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Qualcomm Stock Is Coiling for a Breakout
By Sam Quirke | March 26, 2025
View Qualcomm Stock Is Coiling for a Breakout
If You Could Only Hold 3 Investments for Life, Consider These
By Chris Markoch | March 10, 2025
View If You Could Only Hold 3 Investments for Life, Consider These
Rising E-Commerce Sales May Spark a Stock Breakout—What to Buy
By Gabriel Osorio-Mazilli | March 24, 2025
View Rising E-Commerce Sales May Spark a Stock Breakout—What to Buy
Kohl’s Posts Another Kitchen Sink Quarter, But New CEO Has a Plan
By Jea Yu | March 18, 2025
View Kohl’s Posts Another Kitchen Sink Quarter, But New CEO Has a Plan
Is Myers Industries Poised for a Breakout?
By Jeffrey Neal Johnson | March 7, 2025
View Is Myers Industries Poised for a Breakout?

SYK, BAX, MDT, ISRG, SWK, KO, ABT, BSX, and MMM Company Descriptions

Abbott Laboratories NYSE:ABT

$131.24 -0.11 (-0.08%)

As of 10:36 AM Eastern

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Baxter International NYSE:BAX

$33.69 -0.01 (-0.03%)

As of 10:36 AM Eastern

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Boston Scientific NYSE:BSX

$98.66 -2.14 (-2.12%)

As of 10:36 AM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Intuitive Surgical NASDAQ:ISRG

$493.27 -14.63 (-2.88%)

As of 10:36 AM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Coca-Cola NYSE:KO

$71.21 +0.47 (+0.67%)

As of 10:36 AM Eastern

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Medtronic NYSE:MDT

$87.37 -0.91 (-1.03%)

As of 10:36 AM Eastern

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

3M NYSE:MMM

$146.17 -2.27 (-1.53%)

As of 10:36 AM Eastern

3M Company provides diversified technology services in the United States and internationally. The company's Safety and Industrial segment offers industrial abrasives and finishing for metalworking applications; autobody repair solutions; closure systems for personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, hearing, eye, and fall protection solutions; and natural and color-coated mineral granules for shingles. Its Transportation and Electronics segment provides ceramic solutions; attachment/bonding products, films, sound, and temperature management for transportation vehicles; premium large format graphic films for advertising and fleet signage; light management films and electronics assembly solutions; packaging and interconnection solutions; semiconductor production materials; data centers solutions; and reflective signage for highway, and vehicle safety. The company's Consumer segment provides consumer bandages, braces, supports, and consumer respirators; home cleaning products; retail abrasives, paint accessories, car care DIY products, picture hanging, and consumer air quality solutions; and stationery products. It offers its products through e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers. 3M Company was founded in 1902 and is headquartered in Saint Paul, Minnesota.

Stanley Black & Decker NYSE:SWK

$76.68 -1.03 (-1.33%)

As of 10:36 AM Eastern

Stanley Black & Decker, Inc. engages in the provision of power and hand tools, and related accessories, products, services and equipment for oil and gas, infrastructure applications, commercial electronic security and monitoring systems, healthcare solutions, and mechanical access solutions. It operates through the Tools and Outdoor and Industrial segments. The Tools and Outdoor segment refers to power tools, hand tools, accessories and storage, and outdoor power equipment product lines. The Industrial segment includes the engineered fastening and infrastructure businesses. The company was founded by Frederick T. Stanley in 1843 and is headquartered in New Britain, CT.

Stryker NYSE:SYK

$365.67 -1.87 (-0.51%)

As of 10:36 AM Eastern

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SYK, BAX, MDT, ISRG, SWK, KO, ABT, BSX, and MMM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SYK, BAX, MDT, ISRG, SWK, KO, ABT, BSX, and MMM Earnings

Compare Dividends

Latest SYK, BAX, MDT, ISRG, SWK, KO, ABT, BSX, and MMM Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SYK, BAX, MDT, ISRG, SWK, KO, ABT, BSX, and MMM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SYK, BAX, MDT, ISRG, SWK, KO, ABT, BSX, and MMM Company Descriptions

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools